UKBizDB.co.uk

AMPERSAND MEDICAL COMMUNICATIONS LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Ampersand Medical Communications Limited. The company was founded 8 years ago and was given the registration number 10581276. The firm's registered office is in PRESTON. You can find them at Woodlands Eaves Lane, Woodplumpton, Preston, . This company's SIC code is 70229 - Management consultancy activities other than financial management.

Company Information

Name:AMPERSAND MEDICAL COMMUNICATIONS LIMITED
Company Number:10581276
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:24 January 2017
End of financial year:31 January 2023
Jurisdiction:England - Wales
Industry Codes:
  • 70229 - Management consultancy activities other than financial management

Office Address & Contact

Registered Address:Woodlands Eaves Lane, Woodplumpton, Preston, United Kingdom, PR4 0BH
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Woodlands, Eaves Lane, Woodplumpton, Preston, United Kingdom, PR4 0BH

Director30 April 2019Active
Woodlands, Eaves Lane, Woodplumpton, Preston, United Kingdom, PR4 0BH

Director24 January 2017Active

People with Significant Control

Sarah Louise Feeny
Notified on:24 January 2017
Status:Active
Date of birth:May 1972
Nationality:British
Country of residence:United Kingdom
Address:Woodlands, Eaves Lane, Preston, United Kingdom, PR4 0BH
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (3 months remaining)

Copyright © 2025. All rights reserved.